Jing Wang, University of Colorado Anschutz Medical Campus (IMAGE)

University of Colorado Anschutz Medical Campus

Jing Wang, University of Colorado Anschutz Medical Campus

Caption

Jing Wang, MD, PhD, shows that HDAC inhibitors may sensitize tumors to anti-PD1 immunotherapy.

Credit

University of Colorado Cancer Center

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.